Atos appoints Judith Stewart as Head of Healthcare & Life Sciences, Asia Pacific

By GlobeNewswire

Perth, Australia – November 2, 2026 - Atos, a global leader of AI-powered digital transformation, today announces the appointment of Judith Stewart as Head of Healthcare & Life Sciences for Asia Pacific, reinforcing the company’s commitment to accelerating growth and innovation across the sector and helping organizations harness the potential of artificial intelligence, sovereign technologies and cybersecurity.

Judith brings more than 18 years of international healthcare leadership experience, with a strong track record delivering healthcare reforms and transformations for public and private sector organizations across Australia and the UK. Prior to joining Atos, she held Executive roles for several years within WA Health, most recently as Executive Director for Child and Adolescent Community Health Services in Perth, Western Australia.  

In her new role, Judith will lead Atos’ Healthcare & Life Sciences business across Asia Pacific, with a focus on accelerating growth, strengthening customer relationships, fostering innovation and supporting clients as they navigate an increasingly complex technology landscape.

Daniele Principato, EVP and Head of International Markets at Atos, said:
“Judith brings extensive healthcare leadership experience and a deep understanding of the challenges facing the sector. Her appointment strengthens our Healthcare & Life Sciences capabilities in Asia Pacific and our ability to help clients accelerate transformation while addressing critical priorities around AI, cybersecurity and digital sovereignty.”

Judith Stewart, Head of Healthcare & Life Sciences, Asia Pacific at Atos, said:
“I am delighted to join Atos and look forward to working with our talented teams, customers and partners across Asia Pacific. Healthcare and Life Sciences organizations are navigating significant change, and technology and AI have an important role to play in helping them transform and innovate. I look forward to helping our clients unlock that potential and deliver meaningful outcomes for the communities they serve.”

The appointment reflects Atos’ continued investment in Asia Pacific and its commitment to supporting Healthcare & Life Sciences organizations as they harness advanced technologies to transform healthcare delivery, strengthen resilience and drive sustainable innovation.

***

About Atos

Atos is the Atos Group brand dedicated to AI-powered, secure, end-to-end digital services. Atos designs, develops, and operates critical digital environments that drive performance, resilience and sovereignty, helping public and private organizations worldwide retain control over their data and infrastructures, while meeting regulatory requirements.

With more than 51,000 employees serving over 4,500 clients across 54 countries, Atos helps modernize core IT systems, accelerate cloud and data transformation, strengthen cybersecurity, and deliver secure digital workplace environments to support its clients, its employees and society. Atos also provides consulting and advisory services through its Atos Amplify brand.

A trusted partner in operating complex and mission-critical environments, Atos supports organizations across highly regulated and sovereign contexts.

About Atos Group

Atos Group is a global leader in digital transformation with c. 53,000 employees and annual revenue of c. €7.2 billion, operating in 54 countries under two brands - Atos for services and Eviden for products and systems. European number one in cybersecurity and a leader in cloud, Atos Group is committed to a secure and decarbonized future and provides tailored AI-powered, end-to-end solutions for all industries. Atos Group is listed on Euronext Paris.

Press contact

lucie.leonardi@atos.ai

Attachment


Judith Stewart

Judith Steward, Head of Healthcare & Life Sciences, Atos Asia Pacific

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.